Welcome to our dedicated page for HeartSciences SEC filings (Ticker: HSCSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HeartSciences Inc. filings document the regulatory, financial, governance, and listing disclosures of a Texas healthcare information technology company focused on AI-enabled ECG/EKG solutions. Its SEC reports include 8-K disclosures for quarterly operating results and business updates, including MyoVista Insights commercialization, Medical Device Data System classification, and regulatory matters involving the MyoVista wavECG device.
Proxy and annual-meeting filings cover board elections, equity incentive plan share reserves, amendments to governing documents, auditor ratification, and shareholder voting results. The filing record also documents the company’s Nasdaq-listed common stock and warrants under HSCS and HSCSW, emerging growth company status, capital-structure matters, and Nasdaq listing compliance disclosures.